Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?

JACC Cardiovasc Interv. 2015 Nov;8(13):1647-56. doi: 10.1016/j.jcin.2015.07.020.
No abstract available

Keywords: CABG; PCI; cost effectiveness; quality of life; stent(s).

MeSH terms

  • Cardiology / standards*
  • Clinical Trials as Topic / standards*
  • Coronary Artery Bypass* / adverse effects
  • Coronary Artery Bypass* / mortality
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / surgery
  • Coronary Artery Disease / therapy*
  • Coronary Stenosis / diagnosis
  • Coronary Stenosis / mortality
  • Coronary Stenosis / surgery
  • Coronary Stenosis / therapy*
  • Evidence-Based Medicine / standards*
  • Humans
  • Patient Selection
  • Percutaneous Coronary Intervention* / adverse effects
  • Percutaneous Coronary Intervention* / instrumentation
  • Percutaneous Coronary Intervention* / mortality
  • Practice Guidelines as Topic / standards*
  • Practice Patterns, Physicians' / standards*
  • Registries
  • Risk Assessment
  • Risk Factors
  • Stents
  • Treatment Outcome